3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
Irinotecan
6
Temozolomide
5
Cyclophosphamide
5
Vincristine
4
Magnetic Resonance Spectroscopy
4
Doxorubicin
4
palbociclib
3
X-Rays
3
Phantoms, Imaging
3
Gemcitabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
olaparib
2
ivosidenib
2
ganitumab
2
eribulin
2
cixutumumab
2
cabozantinib
2
abemaciclib
2
Vemurafenib
2
Specimen Handling
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Peripheral Blood Stem Cell Transplantation
2
Nuclear Medicine Department, Hospital
2
Nivolumab
2
LY3023414
2
FANG vaccine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Ewing
×
Imatinib Mesylate
×
Clear all
No trials found.